Review gastric sleeve, gastric bypass, nutrition labs, hydration risk, medication safety, and when bariatric follow-up is still needed
When do the results appear, and how long do they last
Marquardt K, Hartmann C, Wegener F, et al
FDA seeks safety data for Lilly's oral GLP-1 Foundayo The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety data including for liver and cardiovascular side effects
Retatrutide builds on earlier incretin research that first focused on GLP-1 receptor activity, then expanded to dual GLP-1/GIP agonists
Other blogs you might like to check out: Collagen Banking FAQs and Questions to Ask Before a Cosmetic Procedure -Dr